BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2014
View Archived Issues
Scientists develop novel computational tool to rapidly detect genetic alterations in tumors
Read More
AbbVie highlights key events of third quarter 2014
Read More
Treatment with palmithoylethanolamide plus polydatin shows promise in patients with IBS
Read More
R-Pharm CJSC discloses new B7 ligands/CD20 inhibitors
Read More
University of Missouri patents novel SMN2 E-1 ASOs
Read More
Profectus receives DoD funding to support development of vaccines against Ebola and Marburg viruses
Read More
Novartis patent reports new NS4B inhibitors for dengue
Read More
Japanese team designs new FLT3 and/or Trk-A inhibitors
Read More
New autotaxin inhibitors patented by Lilly
Read More
AstraZeneca's acquisition of Almirall's respiratory business complete
Read More
Bristol-Myers Squibb to acquire Galecto Biotech and its novel galectin-3 inhibitor
Read More
Novel cephems reported by Shinogi
Read More
Geron confirms removal of full clinical hold on imetelstat IND
Read More
Myelofibrosis candidate PRM-151 receives fast track designation
Read More
Astellas Pharma offers overview of second quarter of fiscal 2014
Read More
DNA methylation differences found in children with forearm fractures
Read More
Antituberculosis food supplement Nyaditum resae evaluated in clinical trial
Read More
Theravance releases data from first cohorts of proof-of-concept study of TD-6450 for HCV
Read More
Myriad Genetics and AbbVie sign companion diagnostic agreement for BRACAnalysis
Read More
European COMP gives positive opinion on orphan drug designation for IVA-337 in systemic sclerosis
Read More
FDA clears IND for phase I/IIa study of OpRegen for geographic atrophy
Read More
arGEN-X files IND to begin study of ARGX-110 in Waldenstrom's macroglobulinemia
Read More
LabCorp to acquire Covance in early 2015
Read More
Eisai and Arena report phase II data for lorcaserin in smoking cessation
Read More
SUVN-G3031 begins phase I trial in the U.S.
Read More
NIMH creates new unit to support its research domain criteria initiative
Read More